Table 4.
Results of the mixed-effects logistic regression regarding dispensed antimycotics among participants who were dispensed ICS.
| Study group and periodsa | Participants dispensed antimycotics, n (%) | Participants dispensed ICSb, n (%) | t test (df)c | P valuec | 95% CIc | Cohen dc | |||||||
| Control (n=1707) | |||||||||||||
|
|
1 year before | 80 (4.69) | 1707 (73.17) | 0.23 (4662) | .82 | –0.461 to 0.584 | 0 | ||||||
|
|
1 year after | 104 (6.09) | 1707 (73.17) |
|
|
|
|
||||||
| SARA (n=626) | |||||||||||||
|
|
1 year before | 34 (5.43) | 626 (26.83) |
|
|
|
|
||||||
|
|
1 year after | 40 (6.39) | 626 (26.83) |
|
|
|
|
||||||
aThe study periods were 1 year before and 1 year after the implementation of SARA (Service Apothecary Respiratory Advice; in Dutch, Service Apotheek Raad en Advies).
bICS: inhaled corticosteroids; percentages are based on total participants in both groups (n=2333).
cStatistics comparing study groups are reported only in the top row of values.